Yale Bulletin and Calendar

January 14, 2005|Volume 33, Number 15|Two-Week Issue



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Researchers discover a key to blocking
the body's adverse reaction to implants

Blocking a key molecule protects breast implants, permanent catheters, pacemakers, artificial joints, glucose sensors for diabetics and other biomaterials from rejection and damage by the body, according to a study published this month in The American Journal of Pathology.

The more complicated the function of the implant, the more likely it is to be rendered non-functional due to damage induced by the body, says the lead author, Themis Kyriakides, assistant professor of pathology and a member of the interdepartmental program in Vascular Biology and Transplantation at the School of Medicine.

"Implantation of biomaterials and tissue-engineered devices into tissues cause the development of a foreign body reaction that can lead to implant failure," Kyriakides says. "The foreign body reaction has been implicated in the malfunction and failure of numerous devices and implants."

Kyriakides and his colleagues focused on the area of ,contact between the tissue and the implant, or biomaterial, where foreign body giant cells are formed from the fusion of recruited inflammatory cells that attack the implant. The CC chemokine ligand (CCL)-2, previously known as monocyte chemoattractant protein (MCP)-1, is believed to be responsible for the recruitment of foreign body giant cell precursors to the implant site.

This study examined what would happen if the expression or function of CCL2 was eliminated both in mice genetically engineered without the molecule and in other mice where the function of CCL2 was blocked by means of a protein decoy via localized gene delivery.

"What we found is that in the absence of CCL2 these large cells do not form at the site of the implant, therefore protecting the implant from damage," Kyriakides says. He adds that the significance of the finding is discovering a new and more complex role for CCL2 in the foreign body response. The success at blocking the CCL2 in mice using a protein decoy also paves the way for a therapeutic drug target to help sustain implants, he notes.

Co-authors include Matt Foster, Grant Keeney, Annabel Tsai, Cecilia Giachelli and Paul Bornstein, all of the University of Washington; Ian Clark-Lewis of the University of British Columbia in Vancouver, Canada; and Barrett Rollins of Harvard.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Campus responds to tsunami disaster with relief efforts

Alumnus' gift will fund environment center in new F&ES building

Fossils offer insights into consequences of extinction

Festival puts spotlight on the arts at Yale


ENDOWED PROFESSORSHIPS

Campus events mark birthday of Martin Luther King Jr.

Astronomers' maps show dark matter clumps in galaxies

With grant, Yale to develop new programs to retain doctoral students

Exhibits feature landscape paintings in era of British exploration


SCHOOL OF MEDICINE NEWS

Engineer wins prestigious Nishizawa Medal

Colloquium honors retired professor Michael Holquist

Artworks based on sacred themes and Ethiopian iconography . . .

Works by 'mythic figure in modern art' are the focus . . .

Exhibit showcases examples of crimes in ancient history

Evolution is theme of scientist's Terry Lectures

Himalayan kingdom is topic of next Tetelman Lecture

Statue honors accomplishments of Yale's first Chinese student

World Conservation Union adopts resolution by F&ES students

In Memoriam: Dr. Nicholas M. Greene

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home